CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vectorite Biomedical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vectorite Biomedical Inc
3F
No.156, Jiankang Road, Songshan District
Phone: +886 226971100p:+886 226971100 NEW TAIPEI, 221  Taiwan Ticker: 41704170
Business Summary
Vectorite Biomedical Inc is a Taiwan-based company mainly engaged in providing cell product commissioned production services and cell preparations. Products include dendritic cell (DC) vaccines, and natural killer (NK) cell preparations for cancer treatment. The Company also provides immune cell collection, processing and storage services, cell preparation safety testing services, anti-cancer immunity testing services, original design manufacturer (ODM)/ contract development and manufacturing organization (CDMO) services, related medical consulting services, and laboratory quality management services. Products are mainly sold domestically.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations
8734 Testing laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board SuozhuZhang 8/3/2020 6/20/2019
General Manager MingchangOu 1/1/2017 1/1/2017
Head of Finance & Accounting HuijingYou 3/26/2020 3/26/2020
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 43 (As of 12/31/2014)
Outstanding Shares: 43,771,000 (As of 6/30/2024)
Shareholders: 2,062
Stock Exchange: TPO
Fax Number: +886 226971155


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024